Inactive Instrument
Company Guided Therapeutics Inc OTC Bulletin Board
Stocks
US40171F3038
Advanced Medical Equipment & Technology
Business description: Guided Therapeutics Inc

Sales by Activity: Guided Therapeutics Inc
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Developing Innovative Medical Devices | 81K | 13K | 98K | 7K | 767K |
Executive Committee: Guided Therapeutics Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 2023-03-05 |
| Chief Tech/Sci/R&D Officer | 70 | 2010-12-01 |
Composition of the Board of Directors: Guided Therapeutics Inc
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 2016-11-30 |
John Imhoff
BRD | Director/Board Member | 76 | 2006-04-09 |
Michael James
CHM | Chairman | 67 | 2013-09-30 |
Richard Blumberg
BRD | Director/Board Member | 69 | 2016-11-09 |
Alan Grujic
BRD | Director/Board Member | 58 | 2023-03-07 |
Company details: Guided Therapeutics Inc
Guided Therapeutics, Inc.
5835 Peachtree Corners East
30092, Peachtree Corners
+770 242 8723
http://www.guidedinc.com
Other Advanced Medical Equipment & Technology
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.87% | +6.61% | +21.72% | -6.11% | 183B | ||
| -0.33% | -0.09% | -23.18% | +22.79% | 142B | ||
| +5.53% | +6.25% | -4.36% | -20.70% | 134B | ||
| -2.50% | -1.09% | -57.30% | -17.62% | 66.08B | ||
| +3.12% | +3.44% | +18.21% | -0.75% | 51.63B | ||
| +0.16% | -0.38% | -26.97% | -32.13% | 43.38B | ||
| +3.92% | +5.87% | +11.89% | +10.22% | 37.18B | ||
| +3.35% | +3.41% | +6.45% | +42.08% | 36.25B | ||
| +1.82% | +6.10% | -9.86% | -18.72% | 29.51B | ||
| Average | +2.30% | -0.26% | -7.04% | -2.33% | 80.33B | |
| Weighted average by Cap. | +2.79% | -0.60% | -4.90% | -2.61% |

















